Form 4: Axogen Director Sells Shares to Cover Tax Obligations from RSU Vesting

Axogen Director Alan M. Levine sold 4,073 shares of common stock on June 9, 2025, at a weighted average price of $10.61 per share, primarily to satisfy tax obligations related to restricted stock unit vesting.

Summary

• Alan M. Levine, a Director of Axogen, Inc. (AXGN), reported a transaction on June 9, 2025.
• The transaction involved the sale of 4,073 shares of Axogen, Inc. Common Stock.
• The shares were sold at a weighted average price of $10.61 per share, with individual sale prices ranging from $10.47 to $10.61.
• The primary purpose of this sale was to satisfy tax obligations incurred in connection with the vesting of restricted stock units.
• Following this transaction, Alan M. Levine beneficially owns 36,743 shares of Axogen, Inc. Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary sale to cover tax obligations from RSU vesting, which is a common and generally neutral event for insider transactions. It does not reflect a change in confidence or operational performance.

Negatives

• A reduction in the direct beneficial ownership of common stock by a company director, although for a non-discretionary reason.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Industry Context

This Form 4 filing reports a routine insider transaction for tax purposes and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but for a non-discretionary reason, which typically has minimal impact on investor sentiment.

Key Dates

Recommendation

Keywords

Axogen, AXGN, Form 4, Insider Trading, Stock Sale, Director, Alan M. Levine, Restricted Stock Units, RSU, Tax Obligations